The First 30 Egyptian Patients with Type 1 Diabetes on 14-Day Factory Calibrated Glucose Monitoring System: Clinical Usefulness
(2022). The First 30 Egyptian Patients with Type 1 Diabetes on 14-Day Factory Calibrated Glucose Monitoring System: Clinical Usefulness. EKB Journal Management System, 2(1), -. doi: 10.21608/esdlj.2022.455721
. "The First 30 Egyptian Patients with Type 1 Diabetes on 14-Day Factory Calibrated Glucose Monitoring System: Clinical Usefulness". EKB Journal Management System, 2, 1, 2022, -. doi: 10.21608/esdlj.2022.455721
(2022). 'The First 30 Egyptian Patients with Type 1 Diabetes on 14-Day Factory Calibrated Glucose Monitoring System: Clinical Usefulness', EKB Journal Management System, 2(1), pp. -. doi: 10.21608/esdlj.2022.455721
The First 30 Egyptian Patients with Type 1 Diabetes on 14-Day Factory Calibrated Glucose Monitoring System: Clinical Usefulness. EKB Journal Management System, 2022; 2(1): -. doi: 10.21608/esdlj.2022.455721

The First 30 Egyptian Patients with Type 1 Diabetes on 14-Day Factory Calibrated Glucose Monitoring System: Clinical Usefulness

Egyptian Society of Diabetes and Lipidology Journal
Volume 2, Issue 1, April 2022    PDF (66.26 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2022.455721
Abstract
According to the International Diabetes Federation (IDF), Egypt is considered one of the top ten Countries with people living with diabetes. Patients with type 1 diabetes do not have easy access to certified diabetes educators & nutritionists in developing countries like Egypt. Furthermore, management of type 1 diabetes carries great challenges between lowering glycated hemoglobin (HbA1c) level & increasing risk of hypoglycemia. This study was conducted to study the clinical usefulness of 14-day factory-calibrated glucose monitoring system among Egyptian patients with T1D. 
Statistics
Article View: 26
PDF Download: 6